**Sarepta Therapeutics (SRPT)**: Shares in the biotechnology company rocketed around 35% after the Food and Drug Administration approved its Duchenne muscular dystrophy gene therapy for all patients aged 4 and older.
The Nasdaq Composite index has jumped 23% year to date.
(Bloomberg) -- Thomas Matthew Crooks, the 20-year-old gunman who shot and injured former President Donald Trump at a Pennsylvania rally, briefly appeared in an advertisement for BlackRock Inc., the company said on Sunday. Most Read from BloombergTrump Shooting Changes Bidenโs Plan to Revive 2024 CampaignBlackRock Says Gunman From Trump Rally Appeared in Firmโs AdTrump Emerges Defiant From Rally Attack Set to Shake Up โ24 RaceI Was at the Trump Rally Where He Was Shot. Here Is What I SawGlobal Ma
Wall Street's next 10-for-1 stock split is being executed by a company whose business is, arguably, built on a house of cards.
Dividend stocks have been under pressure lately as investors flocked to high-growth tech companies to ride the AI bandwagon. However, amid the latest data showing signs of easing inflation, many analysts believe possible rate cuts from the Federal ...
These fundamentally strong stocks can deliver exceptional returns for patient investors.
It's tempting to think of the Magnificent 7 as a group of stocks that moves in lockstep. That's not true, analysts say.
If you ask investors about dividends, many would say, "the more, the merrier." Monthly dividends from REITs are popular because they allow shareholders to earn money effortlessly through direct deposits. Keep reading to find out how you can earn a ...
Preserve your mental capital by determining just how far you're willing to let a heavy-hitter like Nvidia stock run.
Yes, Nvidia is one of them. But it's not the only semiconductor game in town.
Revenue is climbing at these two drug companies -- and the trend should continue.
